Themes Management Co’s Caris Life Sciences CAI Stock Holding History

Themes Management Co’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.14M	Buy	+37,352	New	+$839K	0.75%	46

Other funds holding CAI

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Security National Bank Omaha, Nebraska $865M AUM 30.55% 1-Year Est. Return

Themes Management Co's CAI Position: Q3 2026 in Review

Themes Management Co opened a new position in Caris Life Sciences (CAI) in Q3 2026: 37,352 shares worth $1.14M. The stake represents 0.75% of the portfolio and ranks #46 among its holdings.

75 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

Themes Management Co held 37,352 shares of Caris Life Sciences worth $1.14M as of Q3 2026.
Caris Life Sciences was a new Themes Management Co position in Q3 2026.
Caris Life Sciences made up 0.75% of Themes Management Co's portfolio in Q3 2026, its #46 holding.
75 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Themes Management Co's 13F filing for Q3 2026, filed 29 Oct 2026.